XZ120
/ Lunan Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 16, 2024
Phase I Study of XZ120 in Malignant Tumors
(clinicaltrials.gov)
- P1 | N=123 | Not yet recruiting | Sponsor: Shandong New Time Pharmaceutical Co., LTD
New P1 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1